Insufficient scRNA-seq data for expression of FBXO5 at single-cell level.
Insufficient scRNA-seq data for expression of FBXO5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 254.34 | 1443 / 1445 | 100% | 13.30 | 183 / 183 |
lung | 100% | 245.89 | 576 / 578 | 99% | 10.38 | 1144 / 1155 |
ovary | 99% | 298.63 | 179 / 180 | 99% | 11.21 | 426 / 430 |
uterus | 100% | 349.94 | 170 / 170 | 98% | 17.50 | 452 / 459 |
breast | 100% | 238.64 | 458 / 459 | 99% | 11.51 | 1102 / 1118 |
stomach | 99% | 199.14 | 357 / 359 | 99% | 11.34 | 282 / 286 |
intestine | 100% | 282.30 | 966 / 966 | 97% | 11.30 | 513 / 527 |
bladder | 100% | 238.24 | 21 / 21 | 96% | 10.42 | 485 / 504 |
brain | 98% | 157.11 | 2585 / 2642 | 97% | 10.05 | 684 / 705 |
prostate | 100% | 280.04 | 244 / 245 | 95% | 5.13 | 476 / 502 |
thymus | 100% | 305.71 | 653 / 653 | 92% | 6.92 | 559 / 605 |
skin | 100% | 528.83 | 1805 / 1809 | 93% | 8.97 | 437 / 472 |
pancreas | 96% | 120.55 | 314 / 328 | 94% | 4.91 | 168 / 178 |
adrenal gland | 100% | 190.17 | 258 / 258 | 71% | 3.09 | 164 / 230 |
kidney | 100% | 193.81 | 89 / 89 | 69% | 3.06 | 625 / 901 |
liver | 100% | 154.58 | 226 / 226 | 51% | 2.67 | 208 / 406 |
adipose | 100% | 253.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.60 | 29 / 29 |
spleen | 100% | 477.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.54 | 45 / 45 |
blood vessel | 99% | 201.86 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 103.82 | 804 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 76% | 605.59 | 703 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 55% | 2.29 | 44 / 80 |
muscle | 52% | 41.45 | 419 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032876 | Biological process | negative regulation of DNA endoreduplication |
GO_0016567 | Biological process | protein ubiquitination |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_1905322 | Biological process | positive regulation of mesenchymal stem cell migration |
GO_2000773 | Biological process | negative regulation of cellular senescence |
GO_0070169 | Biological process | positive regulation of biomineral tissue development |
GO_0006974 | Biological process | DNA damage response |
GO_0007057 | Biological process | spindle assembly involved in female meiosis I |
GO_0051301 | Biological process | cell division |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0001556 | Biological process | oocyte maturation |
GO_0045835 | Biological process | negative regulation of meiotic nuclear division |
GO_0046785 | Biological process | microtubule polymerization |
GO_0016050 | Biological process | vesicle organization |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_1904667 | Biological process | negative regulation of ubiquitin protein ligase activity |
GO_0045841 | Biological process | negative regulation of mitotic metaphase/anaphase transition |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0051444 | Biological process | negative regulation of ubiquitin-protein transferase activity |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0007088 | Biological process | regulation of mitotic nuclear division |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0072687 | Cellular component | meiotic spindle |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_1990948 | Molecular function | ubiquitin ligase inhibitor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0010997 | Molecular function | anaphase-promoting complex binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
Gene name | FBXO5 |
Protein name | F-box only protein 5 (Early mitotic inhibitor 1) |
Synonyms | EMI1 FBX5 |
Description | FUNCTION: Regulator of APC activity during mitotic and meiotic cell cycle . During mitotic cell cycle plays a role as both substrate and inhibitor of APC-FZR1 complex . During G1 phase, plays a role as substrate of APC-FZR1 complex E3 ligase . Then switches as an inhibitor of APC-FZR1 complex during S and G2 leading to cell-cycle commitment . As APC inhibitor, prevents the degradation of APC substrates at multiple levels: by interacting with APC and blocking access of APC substrates to the D-box coreceptor, formed by FZR1 and ANAPC10; by suppressing ubiquitin ligation and chain elongation by APC by preventing the UBE2C and UBE2S activities . Plays a role in genome integrity preservation by coordinating DNA replication with mitosis through APC inhibition in interphase to stabilize CCNA2 and GMNN in order to promote mitosis and prevent rereplication and DNA damage-induced cellular senescence . During oocyte maturation, plays a role in meiosis through inactivation of APC-FZR1 complex. Inhibits APC through RPS6KA2 interaction that increases FBXO5 affiniy for CDC20 leading to the metaphase arrest of the second meiotic division before fertilization (By similarity). Controls entry into the first meiotic division through inactivation of APC-FZR1 complex (By similarity). Promotes migration and osteogenic differentiation of mesenchymal stem cells . . |
Accessions | Q9UKT4 ENST00000229758.8 [Q9UKT4-1] ENST00000367241.3 [Q9UKT4-2] |